Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 22.61 | 27.05 |
| PEG Ratio (TTM) | -0.51 | 1.71 |
| P/S Ratio (TTM) | 0.57 | 2.10 |
| P/B Ratio (TTM) | 4.87 | 1.01 |
| P/FCF Ratio (TTM) | 8.41 | 13.58 |
| Price to 5YR AVG Earnings Ratio | N/A | 10.73 |
| Price to 5YR AVG FCF Ratio | N/A | 22.85 |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.58% | 5.73% |
| ROE (TTM) | 21.43% | 8.43% |
| Net Profit Margin (TTM) | 2.50% | 6.29% |
| ROIC 5YR AVG | N/A | 8.62% |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -20.79% | 41.73% | N/A |
| Revenue | 0.06% | -0.73% | N/A |
| Net Income | -21.46% | 41.58% | N/A |
| Cash Flow | 160.26% | 418.56% | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.78 | 1.58 |
| Quick Ratio (TTM) | 0.34 | 0.95 |
| D/E Ratio (TTM) | 1.55 | 0.68 |
| Interest Coverage (TTM) | 3.94 | 14.56 |
| Piotroski F-Score | 5 | 7 |
| Altman Z-Score | 2.14 | 3.29 |
| LTL to 5YR AVG FCF | N/A | 6.83 |
| Shares Outstanding Growth 5YR AVG | N/A | 2.12% |